Detected mainly in mesenchymal but not in epithelial tissues during embryogenesis, CDH11 is a biomarker for mesenchymal phenotype [6], and is associated with cell lines or tissues of aggressive cancers, especially as an alternatively-spliced variant of CDH11 was identified in breast cancer cell lines and shown to promote invasiveness [7, 8]. This evidence concerns the gene CDH11 and breast cancer.